Jupiter Acquisition Corporation

Status: Liquidated
U=S+W/2 W=S@11.5
IPO Proceeds, $M $157.62M
IPO Date Aug 13, 2021
CEO James N Hauslein
Left Lead Nomura
IPO Cash in Trust 100.0%
SPAC Tenor 24 + 4
IPO Sector Consumer

Consumer and TMT

IPO Geography Global
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Dec 14, 2023
Closing Date Dec 27, 2023
JAQC JAQCU JAQCW

Sign up for Free Trial

No credit card required

Sign in for more on Jupiter Acquisition Corporation:

  • Structure and cap table
  • 7 directors & officers
  • 42 filings and events
  • 3 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
James N Hauslein 61 Chairman, Chief Executive Officer and Chief Financial Officer
James N. Clarke 61 Vice Chairman
Gaurav Burman 49 President and Director
Jonathan Leong 44 Executive Vice President of Strategy and M&A
Robert A. Knox 68 Director
George L. Pita 59 Director
John D. White, Jr. 62 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Nomura Joint BR 8,250,000 units
Ladenburg Thalmann Joint BR 6,750,000
Brookline Capital Markets Joint BR 1
15,000,001 units
Up-Front UW fee 2.00 %
Deferred UW fee
3.50 %

Sign in to view more advisor data.

Filings
Aug 25, 2020 Initial S-1
Sep 3, 2020

Sign In to view filing content.

Sep 10, 2020

Sign In to view filing content.

Feb 19, 2021

Sign In to view filing content.

May 13, 2021

Sign In to view filing content.

Jul 26, 2021

Sign In to view filing content.

Aug 6, 2021

Sign In to view filing content.

Aug 11, 2021

Sign In to view filing content.

Aug 13, 2021

Sign In to view filing content.

Aug 13, 2021 424B4 IPO Prospectus
Aug 23, 2021

Sign In to view filing content.

Sep 29, 2021

Sign In to view filing content.

Jul 8, 2022

Sign In to view filing content.

Mar 13, 2023

Sign In to view filing content.

Mar 24, 2023

Sign In to view filing content.

Apr 6, 2023

Sign In to view filing content.

Apr 17, 2023

Sign In to view filing content.

Apr 24, 2023

Sign In to view filing content.

Jul 19, 2023

Sign In to view filing content.

Jul 24, 2023

Sign In to view filing content.

Aug 14, 2023

Sign In to view filing content.

Aug 25, 2023 425 with Filament Health Q2 2023 results
Sep 1, 2023

Sign In to view filing content.

Sep 22, 2023

Sign In to view filing content.

Oct 2, 2023

Sign In to view filing content.

Oct 13, 2023

Sign In to view filing content.

Nov 7, 2023

Sign In to view filing content.

Nov 8, 2023

Sign In to view filing content.

Nov 13, 2023

Sign In to view filing content.

Nov 13, 2023

Sign In to view filing content.

Nov 15, 2023 425 with Filament Health Q3 2023 results
Nov 21, 2023

Sign In to view filing content.

Nov 24, 2023

Sign In to view filing content.

Dec 4, 2023

Sign In to view filing content.

Dec 5, 2023

Sign In to view filing content.

Dec 6, 2023

Sign In to view filing content.

Dec 8, 2023 DEFA14A with supplement to definitive proxy
Dec 12, 2023

Sign In to view filing content.

Dec 13, 2023

Sign In to view filing content.

Dec 19, 2023

Sign In to view filing content.

Dec 20, 2023

Sign In to view filing content.

Dec 26, 2023

Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.